About BIOMOD

Tested to a higher standard. Pioneering the next generation of peptide delivery.

BIOMOD was founded by a small group of operators with a shared interest in performance, health optimization, and the science underneath both. The founding team carries more than fifty years of combined experience across regulatory affairs, legal, clinical practice, and manufacturing — including a regulatory import/export specialist with active relationships across FDA-registered, cGMP-compliant production facilities. We started this company because the research peptide category had outgrown the standards being applied to it. We are here to raise them.

BIOMOD was built around a single conviction: research peptides — and the consumer-facing formulations derived from peptide chemistry — should be held to a higher standard than the category has historically tolerated. Higher purity.

More disciplined documentation. More rigorous formulation work. And more restraint in how the product is presented. BIOMOD does not sell hype. We sell specification.

Manufacturing footprint

BIOMOD Softgels are manufactured in California. BIOMOD Spray Products are manufactured in Las Vegas, Nevada. BIOMOD Research Peptides are finished — that is, lyophilized and lot-coded — at our Las Vegas facility. Any imported finished goods, where used, are sourced from FDA-registered partner facilities.

BIOMOD invested in formulation chemistry before scaling the catalog. pH ranges, buffer systems, vehicle composition, and excipient selection were developed in-house — not borrowed from competitor labels — and refined against stability and reconstitution endpoints over many iterations. That formulation work produced the World’s First Peptide Softgel™ — a product family BIOMOD originated and continues to expand.

Every BIOMOD research peptide is released against a full analytical panel: chromatographic purity by HPLC-UV/VIS, content assay by HPLC, elemental impurities (arsenic, cadmium, lead, mercury) by ICP-MS, bacterial endotoxins by LAL, and sterility under USP <71>. Testing is performed by an independent third-party laboratory. Certificates of Analysis are issued lot-by-lot and made available through the BIOMOD COA Hub. Every label traces back to a specific test record.

cold at the source. stable in transit

How BIOMOD handles peptide stability from synthesis through delivery.

step 1

Synthesis & lyophilization (USA)

All BIOMOD lyophilized research peptides are synthesized and lyophilized in the United States. Lyophilization removes free water from the compound immediately post-synthesis, locking purity and identity into a stable solid form. This is the form in which the peptide is held — and the form in which it ships.

step 2

Cold storage at the facility

BIOMOD freezes our lyophilized peptides at the point of manufacture and holds them in cold storage at the facility through fulfillment. Softgels and spray products carry a 2-year shelf life and are also kept in temperature-controlled storage from manufacture date through dispatch.

step 3

Synthesis & lyophilization (USA)

Lyophilized peptides in their solid form are shelf-stable through transit periods of days to weeks at standard ambient conditions. This is consistent with peer-reviewed lyophilized peptide stability research and standard practice across the category. BIOMOD has validated our packaging system across thousands of shipments. We ship in protected, insulated packaging engineered to preserve integrity. We do not require dry ice for lyophilized research peptides, and we do not pretend that we do.

step 4

Synthesis & lyophilization (USA)

Upon receipt, transfer lyophilized research peptides to a freezer (−20 °C is standard) until ready for reconstitution. Softgels and spray products do not require refrigeration after delivery — store them per the label printed on each product.

HPLC PURITY

ICP-MS heavy metals

LAL endotoxins

USP sterility

The BIOMOD Difference

Six standards. Held across every research peptide lot.

BIOMOD Standard

98%+ Chromatographic Purity

HPLC-UV/VIS purity confirmed on every lot. Release specification: 98%+. Lot-traceable. Documented on every COA.

BIOMOD Standard

Content Verified by Assay

Every lot is independently assayed by HPLC to verify peptide content matches the label claim. Most suppliers do not publish assay results. BIOMOD does.

BIOMOD Standard

Heavy Metals by ICP-MS

Every lot tested for arsenic, cadmium, lead, and mercury by Inductively Coupled Plasma Mass Spectrometry — the analytical method specified under USP <233>.

BIOMOD Standard

Endotoxins & Sterility

LAL endotoxins and USP <71> sterility on every lot.

BIOMOD Standard

COA with Every Order

A full Certificate of Analysis ships with every order and is available in advance through the BIOMOD COA Hub. Lot, method, LOQ, and result for every test.

BIOMOD Standard

Same-Day Processing

Orders placed before 2 PM PST process the same business day. Secure packaging. Discreet labeling.

What comes next

BIOMOD is not finished. The next phase introduces physical retail locations across Nevada, Florida, Texas, and California; an expanded softgel and spray catalog; and continued investment in delivery technology and peptide chemistry. The brand is being built deliberately. Restraint, repetition, and discipline are the materials.